TipRanks
Hanall Biopharma Co., Ltd. (KR:009420)
:009420
South Korea Market
009420
Hanall Biopharma Co., Ltd.
RESEARCH TOOLSreports

Hanall Biopharma Co., Ltd. (009420) Ratios

― Followers

Hanall Biopharma Co., Ltd. Ratios

KR:009420's free cash flow for Q2 2026 was ₩0.55. For the 2026 fiscal year, KR:009420's free cash flow was decreased by ₩ and operating cash flow was ₩0.12. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.49 1.91 2.46 3.02 3.92
Quick Ratio
 0.84 1.05 1.37 2.16 3.04
Cash Ratio
 0.49 0.56 0.47 0.90 0.59
Solvency Ratio
 -0.27 -0.03 0.03 0.13 0.07
Operating Cash Flow Ratio
 -0.02 -0.05 0.27 0.79 0.88
Short-Term Operating Cash Flow Coverage
 -0.04 -0.15 0.00 42.33 45.06
Net Current Asset Value
₩ 14.01B₩ 21.37B₩ 40.82B₩ 60.05B₩ 66.59B
Leverage Ratios
Debt-to-Assets Ratio
 0.19 0.14 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 0.28 0.20 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 0.22 0.16 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.08 0.08 0.00 0.00 0.00
Financial Leverage Ratio
 1.49 1.39 1.26 1.29 1.27
Debt Service Coverage Ratio
 -0.35 0.16 24.37 9.02 5.80
Interest Coverage Ratio
 4.40 -11.31 3.25 47.85 68.84
Debt to Market Cap
 0.02 0.01 0.00 <0.01 <0.01
Interest Debt Per Share
 878.34 643.43 29.95 26.72 26.22
Net Debt to EBITDA
 -1.09 3.70 -4.46 -4.93 -3.08
Profitability Margins
Gross Profit Margin
52.08%50.97%52.76%55.62%56.34%
EBIT Margin
-10.38%-1.04%0.17%2.47%1.82%
EBITDA Margin
-8.32%1.25%2.41%4.88%4.59%
Operating Profit Margin
2.41%-1.04%0.17%2.27%1.37%
Pretax Profit Margin
-17.06%-3.98%-0.02%2.37%1.75%
Net Profit Margin
-15.31%-3.58%-1.30%2.60%0.23%
Continuous Operations Profit Margin
-15.31%-3.58%-1.19%2.60%0.23%
Net Income Per EBT
89.75%89.94%5971.16%109.56%13.03%
EBT Per EBIT
-707.16%383.51%-13.11%104.79%128.13%
Return on Assets (ROA)
-10.35%-2.47%-0.85%1.46%0.12%
Return on Equity (ROE)
-15.48%-3.44%-1.07%1.88%0.15%
Return on Capital Employed (ROCE)
2.20%-0.89%0.13%1.51%0.81%
Return on Invested Capital (ROIC)
1.69%-0.74%0.13%1.50%0.11%
Return on Tangible Assets
-13.50%-3.46%-1.12%1.47%0.13%
Earnings Yield
-1.03%-0.25%-0.09%0.16%0.03%
Efficiency Ratios
Receivables Turnover
 7.68 7.92 6.92 5.98 3.42
Payables Turnover
 42.42 14.80 6.15 5.31 10.10
Inventory Turnover
 1.91 2.00 1.74 1.85 1.91
Fixed Asset Turnover
 10.48 9.08 7.50 6.94 5.75
Asset Turnover
 0.68 0.69 0.65 0.56 0.52
Working Capital Turnover Ratio
 4.72 3.41 2.20 1.70 1.22
Cash Conversion Cycle
 230.03 204.26 202.99 189.72 261.96
Days of Sales Outstanding
 47.50 46.08 52.72 61.01 106.69
Days of Inventory Outstanding
 191.13 182.84 209.66 197.43 191.40
Days of Payables Outstanding
 8.60 24.66 59.39 68.72 36.14
Operating Cycle
 238.63 228.92 262.38 258.44 298.09
Cash Flow Ratios
Operating Cash Flow Per Share
 -23.78 -46.97 184.57 584.77 495.99
Free Cash Flow Per Share
 -103.46 -66.00 -270.30 403.32 344.92
CapEx Per Share
 79.68 19.03 454.87 181.44 151.07
Free Cash Flow to Operating Cash Flow
 4.35 1.41 -1.46 0.69 0.70
Dividend Paid and CapEx Coverage Ratio
 -0.30 -2.47 0.41 3.22 3.28
Capital Expenditure Coverage Ratio
 -0.30 -2.47 0.41 3.22 3.28
Operating Cash Flow Coverage Ratio
 -0.03 -0.07 6.46 22.97 19.23
Operating Cash Flow to Sales Ratio
 >-0.01 -0.02 0.07 0.22 0.23
Free Cash Flow Yield
-0.23%-0.15%-0.70%0.93%1.96%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -95.63 -392.20 -1.09K 624.15 3.56K
Price-to-Sales (P/S) Ratio
 14.41 14.05 14.11 16.23 8.13
Price-to-Book (P/B) Ratio
 14.90 13.48 11.64 11.76 5.32
Price-to-Free Cash Flow (P/FCF) Ratio
 -433.78 -662.91 -142.99 107.11 51.03
Price-to-Operating Cash Flow Ratio
 -1.94K -931.43 209.41 73.88 35.48
Price-to-Earnings Growth (PEG) Ratio
 -0.15 -1.84 7.17 0.48 -36.61
Price-to-Fair Value
 14.90 13.48 11.64 11.76 5.32
Enterprise Value Multiple
 -174.26 1.13K 580.47 327.77 174.05
Enterprise Value
 2.36T 2.19T 1.95T 2.16T 878.83B
EV to EBITDA
 -174.26 1.13K 580.47 327.77 174.05
EV to Sales
 14.50 14.09 14.00 15.99 7.99
EV to Free Cash Flow
 -436.52 -665.09 -141.90 105.52 50.14
EV to Operating Cash Flow
 -1.90K -934.50 207.81 72.78 34.87
Tangible Book Value Per Share
 2.02K 1.95K 2.30K 3.64K 2.84K
Shareholders’ Equity Per Share
 3.09K 3.24K 3.32K 3.67K 3.31K
Tax and Other Ratios
Effective Tax Rate
 0.10 0.10 -53.65 -0.10 0.87
Revenue Per Share
 3.11K 3.11K 2.74K 2.66K 2.16K
Net Income Per Share
 -476.70 -111.55 -35.59 69.21 4.95
Tax Burden
 0.90 0.90 59.71 1.10 0.13
Interest Burden
 1.64 3.84 -0.13 0.96 0.97
Research & Development to Revenue
 0.07 0.12 0.14 0.18 0.15
SG&A to Revenue
 0.29 0.25 0.22 0.36 0.21
Stock-Based Compensation to Revenue
 >-0.01 <0.01 <0.01 0.01 0.02
Income Quality
 0.05 0.42 -5.19 8.45 100.23
Currency in KRW